| scholarly article | Q13442814 |
| P2093 | author name string | Bianca Schaefer | |
| Soenke Behrends | |||
| P2860 | cites work | Expression and characterization of full-length human heme oxygenase-1: the presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase | Q24296465 |
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571) | Q27639449 | ||
| Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment | Q46493698 | ||
| Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development | Q46681664 | ||
| Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib | Q46892079 | ||
| Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. | Q54005463 | ||
| The binding sites on human heme oxygenase-1 for cytochrome p450 reductase and biliverdin reductase | Q28181839 | ||
| The concept of synthetic lethality in the context of anticancer therapy | Q28268061 | ||
| Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome | Q28287810 | ||
| Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses | Q28394814 | ||
| Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress | Q28510887 | ||
| Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase | Q28569380 | ||
| Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining | Q29614339 | ||
| Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia | Q29615030 | ||
| Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification | Q29618788 | ||
| Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia | Q29620690 | ||
| Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins | Q33797023 | ||
| Heme-oxygenases during erythropoiesis in K562 and human bone marrow cells | Q33963776 | ||
| Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop | Q34075619 | ||
| Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase | Q34208791 | ||
| Heme oxygenase isoforms differ in their subcellular trafficking during hypoxia and are differentially modulated by cytochrome P450 reductase. | Q34251131 | ||
| Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas. | Q34266894 | ||
| Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia | Q35550174 | ||
| Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells | Q35608071 | ||
| Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer | Q35659640 | ||
| The development of imatinib as a therapeutic agent for chronic myeloid leukemia | Q35993288 | ||
| Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer | Q36610787 | ||
| C-Terminal membrane spanning region of human heme oxygenase-1 mediates a time-dependent complex formation with cytochrome P450 reductase | Q37462854 | ||
| Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL. | Q37619813 | ||
| Heme oxygenase-1: emerging target of cancer therapy | Q38426058 | ||
| Therapeutic drug monitoring of imatinib, nilotinib, and dasatinib for patients with chronic myeloid leukemia | Q38462901 | ||
| Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia | Q38571435 | ||
| Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity | Q38984568 | ||
| Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer. | Q39069263 | ||
| Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells | Q39254490 | ||
| PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome | Q39580327 | ||
| Hemin counteracts the repression of Bcl-2 and NrF2 genes and the cell killing induced by imatinib in human Bcr-Abl(+) CML cells | Q39790926 | ||
| Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells | Q39956732 | ||
| Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia | Q40559164 | ||
| Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells. | Q40613241 | ||
| Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage. | Q40620201 | ||
| Optimization of sorting conditions for the selection of stable, high-producing mammalian cell lines | Q40924510 | ||
| Degradation of heme by a soluble peptide of heme oxygenase obtained from rat liver microsomes by mild trypsinization | Q44272938 | ||
| Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients | Q44780594 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | imatinib | Q177094 |
| P304 | page(s) | 67406-67421 | |
| P577 | publication date | 2017-06-27 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Translocation of heme oxygenase-1 contributes to imatinib resistance in chronic myelogenous leukemia | |
| P478 | volume | 8 |
Search more.